Form 4: United Therapeutics Director Tommy G Thompson Reports Stock Transactions

Director Tommy G Thompson reports the acquisition and disposal of United Therapeutics Corp stock and share tracking awards on March 8, 2024.

Summary

• On March 8, 2024, Tommy G Thompson, a director of United Therapeutics Corp, engaged in transactions involving the company's stock and share tracking awards.
• Thompson acquired 2,000 shares of common stock at $88.03 per share through the exercise of share tracking awards.
• Thompson also disposed of 2,000 shares of common stock at $243.05 per share.
• Following these transactions, Thompson directly owns 8,480 shares of common stock.
• Thompson also indirectly owns 5,800 shares through a Family LLC and 8,200 shares through a Trust.
• After the reported transaction, Thompson beneficially owns 5,000 share tracking awards.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director, with neutral sentiment.

Industry Context

Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their trading activities and potential alignment with company performance.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the director's view of the company's stock value.

Key Dates